AKT1 and meningioma: In accordance with previous findings [29], mutations in SMO, KLF4, AKT1, PIK3CA, and TRAF7 were exclusive to the benign methylation class, suggesting that their presence could be used as a surrogate for the methylation profile to identify benign meningiomas [31].